These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Liver disease in cystic fibrosis. Tombazzi CR; Riely CA Rev Med Chil; 2001 Sep; 129(9):1071-8. PubMed ID: 11725473 [TBL] [Abstract][Full Text] [Related]
7. Hepatic calcifications in a patient with Gaucher's disease. Stone R; Benson J; Tronic B; Brennan T Am J Gastroenterol; 1982 Feb; 77(2):95-8. PubMed ID: 7072688 [No Abstract] [Full Text] [Related]
8. Severe liver dysfunction in an infant with cystic fibrosis masquerading as metabolic liver disease. Srikanth KP; Panigrahi I; Thapa BR; Vaiphei K Indian J Pathol Microbiol; 2016; 59(3):339-47. PubMed ID: 27510673 [TBL] [Abstract][Full Text] [Related]
9. Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature. Perdue DG; Cass OW; Milla C; Dunitz J; Jessurun J; Sharp HL; Schwarzenberg SJ Dig Dis Sci; 2007 Oct; 52(10):2638-42. PubMed ID: 17443409 [No Abstract] [Full Text] [Related]
10. Are serum type III procollagen and prolyl hydroxylase useful as noninvasive markers of liver disease in patients with cystic fibrosis? Leonardi S; Giambusso F; Sciuto C; Castiglione S; Castiglione N; La Rosa M J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):603-5. PubMed ID: 9822332 [No Abstract] [Full Text] [Related]
11. Disseminated herpes simplex infection with cystic fibrosis: a case report. Goyal R; Nada R; Das A; Marwaha RK Indian J Pathol Microbiol; 2006 Oct; 49(4):607-9. PubMed ID: 17183874 [TBL] [Abstract][Full Text] [Related]
12. [Significance of nuclear medical methods for demonstration of excretory liver function disorders in children with mucoviscidosis]. Ballke EH; Wiersbitzky H; Wiersbitzky S; Eigel-Hanus G; Reddemann H; Lorenz G Kinderarztl Prax; 1977 Apr; 45(4):162-7. PubMed ID: 875270 [No Abstract] [Full Text] [Related]
13. Pancreatic calcifications in cystic fibrosis (CF). Mariano A; Paolo C; Maurizio M; Serena D Acta Univ Carol Med (Praha); 1990; 36(1-4):171-3. PubMed ID: 2130687 [TBL] [Abstract][Full Text] [Related]
14. [Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases]. Spalinger J Schweiz Med Wochenschr Suppl; 2000; 122():17S-21S. PubMed ID: 12536465 [No Abstract] [Full Text] [Related]
15. Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. Corrigan JJ; Taussig LM; Beckerman R; Wagener JS J Pediatr; 1981 Aug; 99(2):254-7. PubMed ID: 7252687 [No Abstract] [Full Text] [Related]